How do you sell to the NHS?

Selling to the NHS means winning a multi-stakeholder decision inside an organisation with no single buyer. In practice: get a clinical or operational champion who wants the outcome, then do the internal lift for them — a finance-ready business case tied to a real budget line, evidence that satisfies information governance and IT, and a route to purchase through the right framework or procurement process. The clinical yes is the start of the sale, not the end.

Who makes the buying decision in an NHS trust?

No single person. A typical decision needs a clinical or operational champion who wants the outcome, a budget holder who owns the money, a Director of Finance who approves the cashable case, information governance and a DPO for data, IT for integration, and often procurement to run the process. Selling to the NHS is the work of moving all of them, not persuading one.

How long is an NHS sales cycle?

Usually many months, and often longer than a year for anything that touches clinical workflow, patient data or a new budget line. The cycle is long because several people have to approve in sequence and each has a different question. The way to shorten it is not pressure but to reduce the internal work your champion has to do to move it to the next approver.

Why do NHS deals stall after the clinical lead says yes?

Because the champion then has to do a mountain of internal work — build the business case, find the finance evidence, clear information governance, and line up every approver — on top of a full-time clinical job. Enthusiasm fades under the workload and the deal dies of friction, not of a no. The fix is to do that internal lift for them so the ask on them stays small.

Selling to the NHS: How Health-Tech Vendors Actually Win the Deal

Q: Do you need to be on a framework to sell to the NHS?

Not always, but for anything above low value it is usually the cleanest route. Common routes include G-Cloud and other public-sector frameworks, NHS Supply Chain, and trust-level procurement processes. Being on a compliant route removes a procurement objection, but it does not create demand — you still have to win the clinical, operational and finance case first.

A normal B2B playbook assumes a buyer with a budget and the authority to say yes. Selling to the NHS breaks that assumption on day one: many stakeholders, no single budget holder, and a cycle that goes quiet right after your clinical lead falls in love with the product. This is how the decision is really made inside a trust — and how to keep it moving to signature.

Why selling to the NHS breaks a normal sales playbook

The NHS is not one customer. It is hundreds of trusts and integrated care systems, each with its own budgets, priorities and procurement habits. There is rarely a single person who can look at your product, like it, and buy it. That structure is why selling to the NHS defeats vendors who are excellent everywhere else: the tactics that close a commercial SME deal — one champion, one budget, one signature — simply do not map onto a purchase that several people have to approve in sequence, each asking a completely different question.

Get this wrong and you mistake enthusiasm for progress. A clinical lead loving the demo feels like a won deal. It is actually the first of six or seven yeses you need, and the easiest one to get.

Who actually decides inside an NHS trust

Selling to the NHS is the work of moving a group, not persuading a person. On a typical purchase you have to satisfy, in some order:

The clinical or operational champion — wants the outcome and will carry it internally, but has a full-time day job.
The budget holder — owns the money the saving comes out of, and has to agree the benefit is real and theirs.
The Director of Finance — approves the cashable case, and does not buy enthusiasm.
Information governance and the DPO — anything touching patient data has to clear a data-protection and, for digital tools, a technical assessment bar.
IT and integration — how it fits the existing estate, from single sign-on to interoperability.
Procurement — runs the compliant route to purchase once the case is made.

Each of these people can stop the deal, and each needs a different version of your argument. The vendor who wins is the one who arms the champion to answer all of them without having to become a finance analyst, a data-protection officer and a project manager overnight.

How the money works: cash-releasing vs productivity

Finance approves savings, not features. The single distinction that decides most NHS cases is whether a saving is cash-releasing — money that actually comes out of a budget line — or a productivity saving that frees time or capacity but is harder to bank. Conflating the two is the fastest way to lose credibility in the room. The case has to name the specific budget line it reduces, say which kind of saving it is, and express the benefit as pound-value built from the trust's own numbers. That artifact is the heart of the sale, and it has its own detail: how to build an NHS business case finance will approve.

The routes to purchase: frameworks and procurement

Once the case is made, someone has to buy compliantly. For anything above low value that usually means a recognised route rather than a bare purchase order: public-sector frameworks such as G-Cloud, NHS Supply Chain, and trust-level procurement processes. Being on a compliant route removes a procurement objection and reassures the people signing that the paperwork is clean. It is worth doing — but be honest with yourself about what it is: a route to purchase demand you have already created, not a source of demand. No framework listing has ever generated a clinical champion. You still have to win the case first.

The real bottleneck: the deal stalls after the clinical yes

Almost every vendor is good at the first part — getting a clinician genuinely excited. The deal then goes quiet, and it is nearly always for the same reason. The champion has to push the purchase through the trust, and the internal workload is enormous: build the business case, find the finance evidence, work out which budget it comes from, clear information governance, and line up every approver. They are doing this in the gaps of a clinical job. Enthusiasm fades under the load, and the deal dies of friction, not of a no.

The fix is not more product excitement or more chasing. It is to do that internal lift for the champion, so the ask on them stays small and the momentum they started with carries the deal all the way to signature.

What winning the NHS sale actually takes

Selling to the NHS well is a whole motion, built to work as one system, and it is the specialism Disposition is built around:

Positioning built for the NHS buying process — see how a specialist health-tech marketing approach maps to the way trusts actually buy.
A finance-ready case that answers the Director of Finance — the NHS business case in detail.
Sales tools that arm the champion — B2B sales enablement so the argument survives being forwarded to six people who were never in the room.
Leadership to hold it together — a fractional CMO or hands-on go-to-market consultant to own the plan between meetings.

How Throughline keeps the NHS deal moving

The in-between-meetings gap is where NHS deals die, so Disposition builds a product for exactly that moment. Throughline builds the cashable, finance-ready business case from the buyer's own numbers, then hands your champion a ready-to-forward pack mapped to each person who must approve — a tailored note and document for the budget holder, finance, information governance and the rest. The clinical lead is already sold. Throughline means they do not have to become a finance analyst and a project manager to get the deal done, so their momentum survives to the signature. When you want a number to work from, the pricing is public.

Selling to the NHS is a different sport. Here's how the deal actually gets won.